Thermo Fisher Scientific Highlights Digital Science Innovations at Analytica 2018

Thermo Fisher Scientific Highlights Digital Science Innovations at Analytica 2018 MUNICH, April 10, 2018 /PRNewswire/ — Analytica 2018 — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled an expanded portfolio of new instruments and software designed to accelerate discovery and enhance productivity for customers working in pharma and biotech, environmental analysis,... Read more

New Breakthrough Cell Culture Management Technology Designed for Optimal Sample Protection

New Breakthrough Cell Culture Management Technology Designed for Optimal Sample Protection The Thermo Scientific Cell Locker system segregates cells for safe simultaneous growth in a single incubator MUNICH, April 10, 2018 /PRNewswire/ — ANALYTICA 2018 — Cell culture laboratories working with sensitive cell types can now benefit from a patented new technology, developed to revolutionize cell culture... Read more

Thermo Fisher Scientific Announces Its First Cloud-Enabled Biological Safety Cabinet

Thermo Fisher Scientific Announces Its First Cloud-Enabled Biological Safety Cabinet The Thermo Scientific HeraSafe 2030i BSC is designed to optimize contamination control and accelerate productivity across challenging cell culture applications MUNICH, April 10, 2018 /PRNewswire/ — ANALYTICA 2018 — A cloud-enabled biological safety cabinet (BSC) has been specifically developed to address the need for uncompromised contamination control, seamless... Read more

New SPE Solution Streamlines Urine Drug Testing Workflow

Torrance, Calif. (April 10, 2018) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces Strata®-X-Drug B Plus – a solid phase extraction (SPE) sample preparation product for urine drug testing in clinical and forensic toxicology labs. An expansion of Phenomenex’s drug testing product line, the new Drug B Plus... Read more

Agilent Highlights Lab Efficiency through Innovative Solutions at Analytica 2018

Agilent Highlights Lab Efficiency through Innovative Solutions at Analytica 2018 SANTA CLARA, Calif., April 9, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it will showcase its line-up of innovative solutions for laboratory efficiency at Analytica, being held April 10 – 13, in Munich, Germany. This year at the 26th international trade fair for... Read more

University of Pittsburgh and Thermo Fisher Scientific Establish Pharmacogenomics Center of Excellence

University of Pittsburgh and Thermo Fisher Scientific Establish Pharmacogenomics Center of Excellence Collaboration will support translational research that demonstrates the value of PGx in precision medicine PITTSBURGH, April 5, 2018 /PRNewswire/ — Thermo Fisher Scientific and the University of Pittsburgh have established a new Pharmacogenomics (PGx) Center of Excellence that combines expertise and technology in genomics,... Read more

New Compounds Now Available for Antimicrobial Susceptibility Testing: Delafloxacin and Meropenem/Vaborbactam

New Compounds Now Available for Antimicrobial Susceptibility Testing: Delafloxacin and Meropenem/Vaborbactam FDA-cleared microbroth dilution plates provide true minimum inhibitory concentration (MIC) results, facilitating more targeted patient therapy OAKWOOD VILLAGE, Ohio, April 5, 2018 /PRNewswire/ — The antimicrobial delafloxacin, and the combination of meropenem and vaborbactam are now available on FDA-cleared microbroth dilution susceptibility plates, expanding antimicrobial... Read more

Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program

April 5, 2018 at 8:15 AM EDT PDF Version WALTHAM, Massachusetts – April 5, 2018 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program.    Duchenne muscular dystrophy (Duchenne) is the most common genetic disorder diagnosed in... Read more

Agilent and BioTek Join Forces to Create an Integrated Metabolic Analysis and Imaging Platform

Agilent and BioTek Join Forces to Create an Integrated Metabolic Analysis and Imaging Platform SANTA CLARA, Calif., and WINOOSKI, Vt., April 4, 2018 Agilent Technologies Inc. (NYSE: A) and BioTek Instruments, Inc. today announced a new, integrated solution that combines cellular metabolic analysis and imaging technologies. The optimized solution integrates the Agilent Seahorse XFe96/XFe24 Analyzers... Read more

PerkinElmer Prices Offering of Euro-Denominated Senior Notes

April 4, 2018 at 4:15 PM EDT PDF Version WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 4, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of €300 million aggregate principal amount of 0.600% Senior Notes due 2021 at an issue price of 99.950% of the principal... Read more